Vascular Neurology
Lacunar Stroke
Manage suspected lacunar stroke as an acute ischemic stroke while confirming the mechanism with diffusion MRI and vascular-cardioembolic evaluation. Long-term decisions hinge on distinguishing true small-vessel disease from parent-artery, embolic, or incidental infarction and avoiding harmful chronic dual antiplatelet therapy.
Immediate Management
Treat the acute presentation as ischemic stroke until imaging and mechanism establish otherwise
A presumed lacunar syndrome does not justify a lower-acuity pathway.
Activate the acute stroke pathway for sudden focal deficits, obtain urgent brain imaging to exclude hemorrhage, and assess eligibility for intravenous thrombolysis under the institution's acute ischemic stroke protocol. Guidelines for lacunar ischemic stroke recommend intravenous alteplase, antiplatelet treatment, and avoidance of acute blood-pressure lowering according to general acute ischemic stroke guidance rather than lacunar-specific exclusions. PubMed+1PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedPrevention and Management of Cerebral Small Vessel Disease
Noncontrast CT is fast and broadly available but has limited sensitivity for very early ischemia and for brainstem or lacunar infarcts. Obtain MRI with diffusion-weighted imaging when the diagnosis remains uncertain, when posterior circulation or small deep infarction is suspected, or when confirmation will change etiologic attribution; diffusion MRI is more sensitive for acute ischemia. PubMedPubMedStroke and Stroke Mimics: Diagnosis and Treatment - Diseases of the Brain, Head and Neck, Spine 2020–2023 - NCBI Bookshelf
Do not label an acute deficit “lacunar” solely from a pure motor, pure sensory, ataxic hemiparesis, or dysarthria-clumsy hand phenotype. These syndromes support a subcortical localization, but penetrating-artery territory infarction can result from lipohyalinosis, microatheroma at the parent-artery branch ostium, embolism, or large-vessel disease. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH
Prioritize MRI confirmation when CT is unrevealing but the clinical syndrome remains focal and disabling. PubMedPubMedStroke and Stroke Mimics: Diagnosis and Treatment - Diseases of the Brain, Head and Neck, Spine 2020–2023 - NCBI Bookshelf
Avoid routine acute blood-pressure reduction solely because the suspected mechanism is small-vessel disease; follow the acute ischemic stroke protocol. PubMedPubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Initiate rehabilitation assessment during hospitalization when motor, gait, speech, or functional deficits persist. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH
Diagnostic Attribution
Confirm small-vessel occlusion before committing to a lacunar prevention strategy
The imaging lesion, cortical examination, vascular findings, and cardiac evaluation must align.
A working small-vessel occlusion diagnosis requires a compatible lacunar syndrome without cortical dysfunction and either normal neuroimaging or a relevant subcortical or brainstem lesion smaller than 1.5 cm. Hypertension or diabetes supports this mechanism, but neither risk factor establishes it. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
Reclassify the event away from isolated small-vessel occlusion when there is a cardiac embolic source or ipsilateral major extracranial arterial stenosis greater than 50%. This distinction is consequential because embolic disease may require anticoagulation for its underlying indication, whereas anticoagulants are not used for recurrent stroke prevention in cerebral small-vessel disease itself because of disproportionate intracranial hemorrhage risk. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
Evaluate the infarct in an anatomic context. Lipohyalinosis causes concentric hyaline thickening and occlusion of small cerebral vessels, whereas microatheroma or parent-artery plaque can obstruct the perforator origin. A deep infarct therefore warrants review of relevant large-vessel imaging and cardiac-source assessment even when the clinical syndrome is classically lacunar. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH
When MRI is obtained, document whether the lesion is acute on diffusion imaging and whether its location matches the deficit. Follow-up T1-weighted MRI at 90 days shows cavitation in nearly all acute lacunar infarctions, but this is a radiographic evolution marker rather than a requirement for acute diagnosis or treatment. AHA JournalsAHA JournalsCavitation After Acute Symptomatic Lacunar Stroke ...
Cortical dysfunction should trigger reconsideration of the presumed mechanism and review for embolic or large-vessel disease. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
An ipsilateral extracranial stenosis greater than 50% is incompatible with a straightforward small-vessel occlusion classification. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
A cardiac embolic source should redirect secondary prevention toward the identified cause rather than empiric small-vessel anticoagulation. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
| Finding | Mechanistic interpretation | Next action |
|---|---|---|
| Classic lacunar syndrome with no cortical dysfunction | Supports a subcortical small-vessel phenotype. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH | Correlate with CT or MRI and complete vascular-cardiac assessment. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH |
| Relevant subcortical or brainstem lesion smaller than 1.5 cm | Supports small-vessel occlusion when clinical and exclusion criteria also fit. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH | Use as one component of etiologic classification. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH |
| Cardiac embolic source | Challenges a primary small-vessel attribution. PubMed+1PubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIHPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH | Treat the identified cardioembolic mechanism; do not use anticoagulation solely for lacunar disease. PubMedPubMedLacunar Stroke - StatPearls - NCBI Bookshelf |
| Ipsilateral extracranial arterial stenosis greater than 50% | Challenges small-vessel occlusion classification. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH | Pursue large-artery mechanism assessment and management. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH |
| Hypertension or diabetes | Raises pretest probability of cerebral small-vessel disease but is not diagnostic. PubMed+1PubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIHAHA JournalsLacunar Strokes in Patients With Diabetes Mellitus | Maintain a complete mechanism evaluation. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH |
Secondary Prevention
Use single antiplatelet therapy long term for confirmed symptomatic lacunar stroke
Chronic dual antiplatelet therapy is harmful in this population.
For symptomatic lacunar infarction attributed to small-vessel disease, prescribe a single antiplatelet agent for long-term secondary prevention. This is the standard approach in AHA/ASA-aligned care and is recommended in the ESO lacunar stroke guideline. PubMed+2PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedControversies in stroke: Antiplatelet therapy or not for asymptomatic/incidental lacunar infarctionAHA JournalsClinical Relevance of Cerebral Small Vessel Diseases
Do not continue aspirin plus clopidogrel as chronic secondary prevention after lacunar stroke. In SPS3, dual versus single antiplatelet treatment over a mean 3.4 years did not prevent recurrent stroke or cognitive decline and increased death; the trial was stopped early for harm. PubMed+2PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedESO Guideline on covert cerebral small vessel disease - PMCAHA JournalsPredictors of Mortality in Patients With Lacunar Stroke ...
Short, early dual antiplatelet therapy has a separate evidence base for high-risk noncardioembolic TIA, where trials started treatment within 24 hours and found the most favorable benefit-risk balance with 10 to 21 days of therapy. Do not extrapolate that short-course TIA strategy into indefinite aspirin-clopidogrel treatment for MRI-confirmed lacunar stroke. PubMedPubMedEuropean Stroke Organisation (ESO) guidelines on management of transient ischaemic attack - PMC
Do not initiate antiplatelet therapy solely because imaging shows an incidental silent lacunar infarct in a person without prior symptomatic stroke. ESO guidance for covert cerebral small-vessel disease does not recommend antiplatelets for incidental lacunar infarcts because clinical trial evidence is insufficient and low quality. PubMed+1PubMedESO Guideline on covert cerebral small vessel disease - PMCPubMedControversies in stroke: Antiplatelet therapy or not for asymptomatic/incidental lacunar infarction
Confirmed symptomatic small-vessel infarct: long-term single antiplatelet therapy. PubMed+1PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokeAHA JournalsClinical Relevance of Cerebral Small Vessel Diseases
Chronic aspirin plus clopidogrel after lacunar stroke: avoid because SPS3 found harm without recurrent-stroke benefit. PubMed+1PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedESO Guideline on covert cerebral small vessel disease - PMC
Incidental silent lacune: manage vascular risk factors; do not treat the imaging finding itself with routine antiplatelet therapy. PubMed+1PubMedESO Guideline on covert cerebral small vessel disease - PMCPubMedControversies in stroke: Antiplatelet therapy or not for asymptomatic/incidental lacunar infarction
Vascular Prevention
Prioritize sustained blood-pressure control, lipid lowering, and functional recovery
Risk-factor control is the principal disease-modifying strategy once the acute phase has passed.
Institute long-term blood-pressure control after the acute stroke period. In a meta-analysis of target-based intensive versus standard blood-pressure trials after stroke, lower targets reduced recurrent stroke by 22% (hazard ratio 0.78; 95% CI 0.64-0.96) without evidence of harm. However, the evidence was driven predominantly by RESPECT, and the lowest systolic pressure that may be unsafe in susceptible subgroups remains undefined. AHA JournalsAHA JournalsLong-Term Secondary Prevention: Management of Blood ...
For recent lacunar stroke specifically, SPS3 compared systolic targets of 130 to 149 mm Hg versus a lower target, but intensive blood-pressure lowering did not clearly reduce recurrent stroke or prevent cognitive decline in the lacunar-specific guideline assessment. Use individualized antihypertensive treatment with attention to symptoms and comorbidity rather than assuming that an arbitrarily low systolic target is universally beneficial. AHA Journals+1AHA JournalsOptimum Blood Pressure Target After Lacunar StrokePubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Use lipid-lowering therapy according to current secondary stroke prevention guidance. In SPARCL post hoc data, statin efficacy in patients with lacunar infarction was similar to the overall trial cohort; among patients with baseline small-vessel disease, hemorrhagic stroke increased but ischemic stroke decreased, yielding an overall benefit similar to the trial population. PubMed+1PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedPrevention and Management of Cerebral Small Vessel Disease
Address smoking, exercise, healthy lifestyle measures, and obesity as part of secondary prevention. Monitor for cognitive decline, gait or mobility impairment, and mood symptoms, which are clinically relevant manifestations of cerebral small-vessel disease and may determine rehabilitation and longitudinal care needs. PubMedPubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Begin or intensify long-term antihypertensive therapy after the acute phase; monitor for intolerance when pursuing lower pressures. AHA Journals+1AHA JournalsLong-Term Secondary Prevention: Management of Blood ...PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke
Use lipid lowering according to secondary stroke prevention guidance, recognizing the ischemic-versus-hemorrhagic tradeoff in extensive small-vessel disease. PubMed+1PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedPrevention and Management of Cerebral Small Vessel Disease
Arrange physical and occupational rehabilitation when residual deficits limit independence. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH
Incidental versus symptomatic disease
Separate a covert lacune from a clinical ischemic stroke at every follow-up visit. A symptomatic lacunar infarct warrants secondary stroke prevention with single antiplatelet therapy, blood-pressure control, lipid lowering, and lifestyle measures; an incidental lesion does not by itself establish an antiplatelet indication. PubMed+2PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedESO Guideline on covert cerebral small vessel disease - PMCPubMedControversies in stroke: Antiplatelet therapy or not for asymptomatic/incidental lacunar infarction
Follow-up
Reassess mechanism when recurrence or imaging patterns do not fit a single perforator infarct
Recurrence should prompt etiologic reconsideration rather than automatic escalation of antiplatelet therapy.
For recurrent ischemic events despite apparent lacunar disease, repeat the etiologic review for a cardiac embolic source, relevant extracranial stenosis, and lesion-clinical mismatch. The original small-vessel designation is only probable when clinical findings, imaging, and diagnostic studies are concordant and competing causes have been excluded. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
Do not respond to recurrence by adding indefinite aspirin-clopidogrel therapy without a separate indication. SPS3 provides direct evidence that chronic dual antiplatelet treatment after lacunar stroke increases mortality without preventing recurrent stroke. PubMed+2PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedESO Guideline on covert cerebral small vessel disease - PMCAHA JournalsPredictors of Mortality in Patients With Lacunar Stroke ...
If follow-up MRI demonstrates a cavity at approximately 90 days, interpret this as expected evolution of an acute lacunar infarct rather than treatment failure. New diffusion-positive lesions or a cortical pattern, by contrast, should reopen the mechanism assessment. AHA Journals+1AHA JournalsCavitation After Acute Symptomatic Lacunar Stroke ...PubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
New cortical deficits or cortical infarction pattern: revisit embolic and large-vessel causes. PubMedPubMedIschemic Stroke - StatPearls - NCBI Bookshelf - NIH
Recurrent event with no new mechanism identified: optimize blood pressure, lipid lowering, lifestyle intervention, and adherence rather than defaulting to chronic dual antiplatelet therapy. AHA Journals+2AHA JournalsLong-Term Secondary Prevention: Management of Blood ...PubMedEuropean stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic strokePubMedESO Guideline on covert cerebral small vessel disease - PMC
Persistent disability: reassess rehabilitation needs rather than assuming neurologic recovery is complete at discharge. PubMed+1PubMedLacunar Stroke - StatPearls - NCBI BookshelfPubMedAcute Stroke - StatPearls - NCBI Bookshelf - NIH
References
- The Lancet Specialty Collections: Hypertension — www.thelancet.com · www.thelancet.com
- Blood-pressure targets in patients with recent lacunar stroke — www.thelancet.com · www.thelancet.com
- Cavitation After Acute Symptomatic Lacunar Stroke ... — www.ahajournals.org · www.ahajournals.org
- Optimum Blood Pressure Target After Lacunar Stroke — www.ahajournals.org · www.ahajournals.org
- New Insights Into Cerebrovascular Pathophysiology and ... — www.ahajournals.org · www.ahajournals.org
- Long-Term Secondary Prevention: Management of Blood ... — www.ahajournals.org · www.ahajournals.org
- European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- ESO Guideline on covert cerebral small vessel disease - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Controversies in stroke: Antiplatelet therapy or not for asymptomatic/incidental lacunar infarction — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Prevention and Management of Cerebral Small Vessel Disease — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Lacunar Stroke - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Ischemic Stroke - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Acute Stroke - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Cryptogenic stroke: definitions and management — ashpublications.org · ashpublications.org
- Stroke and Stroke Mimics: Diagnosis and Treatment - Diseases of the Brain, Head and Neck, Spine 2020–2023 - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Stroke and transient ischaemic attack in over 16s: ... — www.nice.org.uk · www.nice.org.uk
- Clinical Relevance of Cerebral Small Vessel Diseases — www.ahajournals.org · www.ahajournals.org
- Cerebral Small Vessel Disease–Related Dementia — www.ahajournals.org · www.ahajournals.org
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ... — www.ahajournals.org · www.ahajournals.org
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... — www.ahajournals.org · www.ahajournals.org
- Lacunar Strokes in Patients With Diabetes Mellitus — www.ahajournals.org · www.ahajournals.org
- Current and Future Treatments of Vascular Cognitive ... — www.ahajournals.org · www.ahajournals.org
- Predictors of Mortality in Patients With Lacunar Stroke ... — www.ahajournals.org · www.ahajournals.org
- European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov